Lithotripsy Advantage in Calcified Peripheral Vessels Holds Up at 1 Year
ATLANTA — Intravascular lithotripsy (IVL) beat percutaneous transluminal angioplasty (PTA) for keeping calcified peripheral artery lesions open at 1 year, the Disrupt PAD III trial showed. Primary patency at 1 year was 80.5% for the IVL arm compared with 68.0% for the PTA arm (P=0.017), reported William Gray, MD, co-director of the Lankenau Heart Institute […]